Accordingly, the brain infarct volume and recovery of motor function were enhanced by genetic deletion of TRPM4, although the protective effect of TRPM4 silencing on motor function was only transient and ceased at day 5 post-intervention (Loh et al., 2014). This evidence concerns the gene TRPM4 and brain infarction.